Apollo Hospitals Enterprise Ltd

Meeting Details

• Date and time: November 5, 2026 at 3:00 PM IST.
• Type and mode: group investor conference call, virtual.
• Event/organiser: Apollo Hospitals Enterprise Ltd. (Q2 FY27 Earnings Conference Call).
• Notes: results announced on Nov 4, 2026; call discusses results.

Participants

• Managing Director, Apollo Hospitals Enterprises Ltd.
• Group Chief Financial Officer, AHEL.
• President & CEO, Hospitals Division.
• CEO, Apollo HealthCo Ltd.
• CEO, AHLL.
• CFO, Apollo HealthCo Ltd.
• CFO, Pharmacy business.

Purpose

• Purpose: earnings results discussion for Q2 FY27.

Availability

• Earnings presentation will be available on the corporate website.

Additional Notes

• Pre-registration required to access the conference call.

Apollo Hospitals Enterprise Ltd - Closure of Trading Window

IEPF transfer notice

• Transfer of equity shares to IEPF under IEPF rules for 2018-19 to 2025-26.
• Newspaper ads published in Business Standard (English) and Tamil newspaper.
• Registrar/transfer agent: Integrated Registry Management Services Pvt Ltd; contact info provided.
• Shareholders to provide updated addresses by Sept 30, 2026.
• Information also posted on Apollo Hospitals' website.
• Filing/notice date: 3 September 2026.

Unclaimed shares transfer to IEPF

• Transfer of seven-year unclaimed shares to IEPF under applicable rules.
• Newspaper notices published in Business Standard and Tamil edition.
• Shares in 2018-2019 to 2025-2026 financial years affected.
• Transfer to IEPF to occur on or before 30 September 2026.
• Shareholders with unclaimed holdings should update their details to prevent transfer.
• Registrar and transfer agent: Integrated India Pvt Ltd; Chennai address; email einward@integratedindia.in.

Financial performance

• Revenue from operations: ₹252,285m (FY26).
• PAT to owners: ₹19,417m.
• Basic EPS ₹135.04; diluted ₹134.94.
• EBITDA: ₹37,693m.
• EBITDA margin: 14.9%.
• PAT margin: 7.7%.
• Dividend per share: total ₹20; interim ₹10, final ₹10.
• Net debt: ₹45,417m.
• Net debt to equity: 46%.
• Total borrowings: ₹56,585m.

AGM Details

• Date and time: 25 August 2026 at 10:15 IST; mode: VC.
• Record date: 18 August 2026.
• Attendance: 81 members; meeting conducted via Video Conferencing.

Key Resolutions & Outcomes

• Resolution 1 (Ordinary): Adopt standalone and consolidated financial statements; passed with 99.999% in favour.
• Resolution 2 (Ordinary): Confirm interim dividend and declare final dividend; passed with 99.967% in favour.
• Resolution 3 (Ordinary): Re-appoint Sangita Reddy; passed.
• Resolution 4 (Ordinary): Re-appoint Dr. Prathap C. Reddy; passed.
• Resolution 5 (Special): Re-appoint Prathap C. Reddy as Executive Chairman for two years; passed.
• Resolution 6 (Special): Re-appoint Rama Bijapurkar as Independent Director for five years; passed.
• Resolution 7 (Special): Private placement of debentures up to Rs 7,500 million; passed.
• Resolution 8 (Ordinary): Ratify Cost Auditor remuneration for year ending 31 Mar 2027; passed.

Meeting Details

• Date: August 13, 2026; time not disclosed
• Type: presentation; mode not disclosed
• Event/organiser: Apollo Hospitals Enterprise Limited
• Purpose: discuss unaudited Q1 FY27 results

Participants

• Key company participants: Senior Vice President – Finance; Company Secretary

Availability

• Transcript of the presentation available on the company website

Meeting Details

• Event: Analyst call on financial results for the quarter ended June 30, 2026.
• Type/Mode: Audio recording (virtual analyst call) available online.
• Key participants: Sr. Vice President – Finance and Company Secretary.
• Purpose: Discussion of Q2 2026 results.
• Availability: Recording is available on the company website.

Business overview

• Core business spans Healthcare Services, Diagnostics & AHLL, and Digital Health & Pharmacy Distribution via Apollo HealthCo.
• AHLL's Mother & Child and Fertility units to combine into a major maternity platform.
• Apollo HealthCo is the omni-channel platform integrating digital and offline healthcare services.

Operational highlights

• Commissioned five new hospitals in the last two quarters.
• Total census beds after expansion ~14,100.
• Current beds at Q1FY27: 9,857.
• Expansion plan adds about 1,000 census beds; total project cost ₹11,150 cr, ₹7,500 cr remaining.
• Geographic expansion across Pune, Delhi, Hyderabad, Kolkata, and other Tier-1/Tier-2 cities.
• Of 1,000 beds, 380 operational; 620 to be activated in 12–18 months.

Financial performance

• Consolidated revenue ₹70,435 mn; YoY growth 21%.
• Consolidated EBITDA ₹10,920 mn; margin 15.5%.
• PAT ₹5,805 mn; growth 34%.
• ROCE 28.5% in Q1FY27.
• Hospital segment occupancy 70% established units; average revenue per in-patient ₹186,630.

Capital structure & liquidity

• Cash and equivalents ₹23,560 mn; liquid funds ₹18,555 mn.
• Consolidated net debt ₹7,481 mn.

Strategic priorities & outlook

• Composite scheme approved; demerger of OCP and Apollo 24x7 into NewCo; amalgamation with Keimed.
• Listing expected by Q4 FY27.
• Target run-rate revenue ₹250 bn; EBITDA margin 6.5–7.0%.
• Plan bolt-on acquisitions in Tier-1 cities.

Risks & mitigation

• Execution risk in phased 1,000-bed expansion.
• Integration risk from HealthCo demerger and amalgamation.
• One-time network investment impacting margins.

Governance & leadership

• Shareholder approvals secured for composite scheme; NewCo listing.
• NewCo to be Indian-owned and controlled (IOCC) post approvals.
• Automatic listing of NewCo; AHEL shareholders directly participate.
• Post-merger listing expected by Q4 FY27.

Meeting Details

• Date of investor presentation: August 12, 2026.
• Event type: investor presentation for Q1 FY27 results.
• Organiser: Apollo Hospitals Enterprise Limited.

Participants

• Key company participants: Senior Vice President - Finance and Company Secretary.

Purpose

• Discuss Q1 FY27 results (three months ended June 30, 2026).
• Presentation to investors available on the company website.

Additional Notes

• Presentation enclosed with the filing and uploaded on the company's website.